occurring antimalarial compound from Artemisia annua, or sweet wormwood, in human
endometrial cancer cells. Artemisinin induced a G1 cell cycle arrest in cultured human
Ishikawa endometrial cancer cells and downregulated cyclin-dependent kinase-2 (CDK2)
and CDK4 transcript and protein levels. Analysis of CDK4 promoter-luciferase reporter
constructs showed that the artemisinin ablation of CDK4 gene expression was accounted for …